Dr. Martens (CHIX:DOCSL) Notes Receivable: £0.0 Mil (As of Mar. 2026)


CHIX:DOCSL Dr. Martens PLC CHIX:DOCSL
52 GF Score
Price £0.70
GF Value £0.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Notes Receivable?

Dr. Martens CHIX:DOCSL +1.30% 52 Notes Receivable is £0.0 Mil as of Mar. 2026. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review.

Dr. Martens's Notes Receivable for the quarter that ended in Mar. 2026 was £0.0 Mil.

Dr. Martens Notes Receivable Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Notes Receivable Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:DOCSL
52GF Score
Dr. Martens PLC CHIX:DOCSL
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of £0.0 Mil mean?
Dr. Martens (CHIX:DOCSL) has a Notes Receivable of £0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Dr. Martens and its competitors.
Is Dr. Martens' Notes Receivable too high?
Dr. Martens' current Notes Receivable is £0.0 Mil. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Notes Receivable compare to NKE and DECK?
Dr. Martens' Notes Receivable of £0.0 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Manufacturing - Apparel & Accessories company?
A good Notes Receivable depends on the Manufacturing - Apparel & Accessories industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Dr. Martens and its competitors. Dr. Martens's current Notes Receivable is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.70 — trading 2.5% below its estimated fair value. The current Notes Receivable is £0.0 Mil. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current Notes Receivable is £0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of £0.70 is trading 2.5% below its estimated GF Value™ of £0.72. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for CHIX:DOCSL:

  • Notes Receivable: £0.0 Mil
  • GF Value™: £0.72 vs. price of £0.70 (2.5% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score

Get the complete analysis for CHIX:DOCSL

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.70
Price
£0.72
GF Value